Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

TuHURA to Present 3 DOR Posters at ASH 2026

TuHURA Biosciences, Inc. (NASDAQ:HURA) announced on November 4, 2026, that it will present three poster presentations on its Delta Opioid Receptor (DOR) research at the 68th American Society of Hematology Annual Meeting and Exposition, scheduled for December 12-15, 2026, in New Orleans, Louisiana.

Nitish Kishor | 04 November 2026

Clarivate Launches Tender Offers for 2028 and 2029 Notes

Clarivate Plc disclosed via an 8-K press release dated November 4, 2026, that its wholly-owned subsidiary Clarivate Science Holdings Corporation has commenced cash tender offers to purchase up to $500,000,000 aggregate principal amount of its outstanding 3.875% Senior Secured Notes due 2028 and 4.875% …

Manish Choudhary | 04 November 2026

Cullinan CLN-049 Phase 1 Data: 53% ORR at 12 µg/kg Subset

Cullinan Therapeutics, Inc. filed a Current Report on Form 8-K on November 4, 2026, disclosing updated clinical data from its CLN-049 Phase 1 dose escalation trial in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndrome, ahead of a December presentation at …

Anjali Anand | 04 November 2026

SelectQuote Posts $20.3M Net Loss in Q1 Fiscal 2027

SelectQuote, Inc. filed a Form 10-Q with the SEC on November 4, 2026, covering the quarterly period ended September 30, 2026, reporting a net loss of $20,301 thousand for the three months ended on that date.

Anjali Anand | 04 November 2026

Labcorp CFO Julia Wang to Speak at UBS Healthcare Conference

Labcorp Holdings Inc. filed an 8-K on November 4, 2026 under Regulation FD disclosing that Chief Financial Officer Julia Wang will speak at the UBS Global Healthcare Conference on November 10, 2026.

Vinay Lochav | 04 November 2026

Neostellar Capital Q3 2026: NAV Rises to $12.64 Per Share

Neostellar Capital Corp. (formerly SuRo Capital Corp.) filed its Form 10-Q for the quarterly period ended September 30, 2026 with the SEC on November 4, 2026, reporting a net asset value of $12.64 per share and a nine-month net change in net assets from …

Shwetambri Chauhan | 04 November 2026

Circle Internet Group Q3 2026 10-Q: Share Count and Product Suite

Circle Internet Group, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, and disclosing share counts as of October 29, 2026, alongside detailed descriptions of its digital asset product suite.

Aakashdeep | 04 November 2026

Allison Transmission Q3 2026: Net Sales Hit $1.534B

Allison Transmission Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the U.S. Securities and Exchange Commission on November 4, 2026, reporting third-quarter net sales of $1.534 billion and net income of $191 million.

Anjali Anand | 04 November 2026

FTC Solar Q3 2026: Revenue Rises, Deficit Narrows to $17.4M

FTC Solar, Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the period ended September 30, 2026, disclosing revenue growth, a reduced stockholders' deficit, and a significant decline in warrant liability.

Shwetambri Chauhan | 04 November 2026

UroGen Pharma Q3 2026: Revenue Triples to $89M

UroGen Pharma Ltd. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, reporting a sharp increase in revenue and a narrowed net loss compared to the prior-year quarter.

Vinay Lochav | 04 November 2026
Support

Hi! How can we help you today?

Loading…